RIGL — Rigel Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $882.62m
- $826.53m
- $294.28m
Brief: Rigel Pharmaceuticals Acquires U.S. Rights To GAVRETO
Brief: Rigel Pharma Provides Business Update
Brief: Rigel Pharmaceuticals and MD Anderson Announce Strategic Alliance to Advance REZLIDHIA® (Olutasidenib) in AML and Other Cancers
Rigel Pharmaceuticals Inc expected to post a loss of 7 cents a share - Earnings Preview
Rigel Pharmaceuticals Inc expected to post a loss of 7 cents a share - Earnings Preview
Rigel Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary
Rigel Pharmaceuticals Inc expected to post a loss of 8 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Ruth's Hospitality, Mirion Technologies, Qualcomm
U.S. STOCKS ON THE MOVE-CVS Health, Match Group, Western Union
U.S. STOCKS ON THE MOVE-Lumen Technologies, Estee Lauder, ImmunoGen
Rigel Pharmaceuticals rises after upbeat results
Brief: Rigel Pharmaceuticals posts Q1 revenue of USD 26.1 million
Brief: Rigel Reports First Quarter 2023 Financial Results And Provides Business Update
Rigel Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary
Rigel Pharmaceuticals Inc expected to post a loss of 10 cents a share - Earnings Preview
Brief: Rigel Pharmaceuticals Inc Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
U.S. STOCKS ON THE MOVE-WeWork, Silvergate, Rivian, CrowdStrike
Rigel Pharma jumps on strong Q4 revenue
U.S. RESEARCH ROUNDUP-Tesla, Oracle, Caredx